Exhaled nitric oxide is not reduced in infants with cystic fibrosis

Franklin P. J., Hall G. L., Moeller A., Horak F., Brennan S., Stick S. M.

Source: Eur Respir J 2006; 27: 350-354
Journal Issue: February
Disease area: Paediatric lung diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Franklin P. J., Hall G. L., Moeller A., Horak F., Brennan S., Stick S. M.. Exhaled nitric oxide is not reduced in infants with cystic fibrosis. Eur Respir J 2006; 27: 350-354

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Reduced exhaled nitric oxide in infants with cystic fibrosis
Source: Eur Respir J 2004; 24: Suppl. 48, 384s
Year: 2004

Airway acidification and exhaled nitric oxide in cystic fibrosis
Source: Eur Respir J 2003; 22: Suppl. 45, 514s
Year: 2003

Fractional exhaled nitric oxide levels in patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2016 – Asthma, bronchiectasis, and the risk factors for respiratory morbidity
Year: 2016


Exhaled nitric oxide in cystic fibrosis: relationships with airway and lung vascular impairments
Source: Eur Respir J 2009; 34: 117-124
Year: 2009



Glucocorticoid treatment reduces exhaled nitric oxide in cystic fibrosis patients
Source: Eur Respir J 2001; 17: 1267-1270
Year: 2001



Effect of inhaled L-arginine on airway nitric oxide in cystic fibrosis patients
Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle
Year: 2005


Differences in exhaled nitric oxide levels between patients with cystic fibrosis and atopic bronchial asthma
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children
Year: 2013


Exhaled nitric oxide in stable adult cystic fibrosis patients, during exacerbation and following CFTR-modifying treatment
Source: Eur Respir J, 53 (5) 1802259; 10.1183/13993003.02259-2018
Year: 2019



Exhaled nitric oxide in infants: a marker of inflammation?
Source: Eur Respir Monogr 2010; 49: 56-70
Year: 2010


Bronchial but not alveolar nitric oxide is decreased in adults with cystic fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 404s
Year: 2005

Airway nitric oxide production in patients with cystic fibrosis increases with ivacaftor therapy
Source: International Congress 2015 – Cystic fibrosis: assessment and treatment
Year: 2015


Orally and nasally exhaled nitric oxide and nitrite in asthmatic and cystic fibrosis patients
Source: Eur Respir J 2003; 22: Suppl. 45, 131s
Year: 2003

Antibiotic treatment decreases exhaled nitric oxide levels in cystic fibrosis patients
Source: Eur Respir J 2004; 24: Suppl. 48, 384s
Year: 2004

Nitric oxide production by the alveolar compartment of the lungs in cirrhotic patients
Source: Eur Respir J 2009; 34: 138-144
Year: 2009



Nasal nitric oxide
Source: Eur Respir Monogr 2010; 49: 71-81
Year: 2010


An increase in exhaled nitric oxide is not associated with activity in pulmonary sarcoidosis
Source: Eur Respir J 2004; 24 : 609-614
Year: 2004



Evaluation of exhaled nitric oxide in idiopathic interstitial lung diseases
Source: International Congress 2015 – IIPs: orphan
Year: 2015


Exhaled nitric oxide and pulmonary function tests in children with asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 759s
Year: 2007

Domiciliary exhaled nitric oxide and eosinophilic airway inflammation in adults with asthma
Source: Eur Respir J 2016; 48: 242-244
Year: 2016


Fractional exhaled nitric oxide for eosinophilic inflammation in stable COPD
Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Year: 2017